News
KLTOW
0.0541
-9.83%
-0.0059
Weekly Report: what happened at KLTOW last week (1230-0103)?
Weekly Report · 1d ago
Weekly Report: what happened at KLTOW last week (1223-1227)?
Weekly Report · 12/30/2024 11:49
Weekly Report: what happened at KLTOW last week (1216-1220)?
Weekly Report · 12/23/2024 11:57
Weekly Report: what happened at KLTOW last week (1209-1213)?
Weekly Report · 12/16/2024 11:59
DR. MERIT CUDKOWICZ, RENOWNED ALS EXPERT AT MASSACHUSETTS GENERAL HOSPITAL (MGH), JOINS KLOTHO NEUROSCIENCES’ SCIENTIFIC ADVISORY BOARD
Reuters · 12/09/2024 16:00
Weekly Report: what happened at KLTOW last week (1202-1206)?
Weekly Report · 12/09/2024 11:57
FORMER MERCK USA PRESIDENT JOINS KLOTHO NEUROSCIENCES’ BOARD OF DIRECTORS
Reuters · 12/03/2024 16:00
Weekly Report: what happened at KLTOW last week (1125-1129)?
Weekly Report · 12/02/2024 11:58
Weekly Report: what happened at KLTOW last week (1118-1122)?
Weekly Report · 11/25/2024 11:47
Weekly Report: what happened at KLTOW last week (1111-1115)?
Weekly Report · 11/18/2024 11:43
KLOTHO NEUROSCIENCES - SOUGHT TERMINATION OF LICENSING AGREEMENT SINCE LICENSED RIGHTS ARE NO LONGER CORE TO CO'S BUSINESS, RESEARCH PLANS
Reuters · 11/13/2024 11:17
Weekly Report: what happened at KLTOW last week (1104-1108)?
Weekly Report · 11/11/2024 12:00
Weekly Report: what happened at KLTOW last week (1028-1101)?
Weekly Report · 11/04/2024 11:56
Weekly Report: what happened at KLTOW last week (1021-1025)?
Weekly Report · 10/28/2024 11:47
Weekly Report: what happened at KLTOW last week (1014-1018)?
Weekly Report · 10/21/2024 11:42
CO-FOUNDER OF SHIRE PHARMACEUTICALS APPOINTED AS CHIEF OPERATING OFFICER OF KLOTHO NEUROSCIENCES
Reuters · 10/15/2024 10:00
Weekly Report: what happened at KLTOW last week (1007-1011)?
Weekly Report · 10/14/2024 12:17
Weekly Report: what happened at KLTOW last week (0930-1004)?
Weekly Report · 10/07/2024 12:04
Weekly Report: what happened at KLTOW last week (0923-0927)?
Weekly Report · 09/30/2024 11:55
DR. ROBERT LANGER, CO-FOUNDER OF MODERNA, JOINS SCIENTIFIC ADVISORY BOARD OF KLOTHO NEUROSCIENCES, INC. (KLTO)
Reuters · 09/30/2024 00:30
More
Webull provides a variety of real-time KLTOW stock news. You can receive the latest news about Klotho Neurosciences, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About KLTOW
ANEW Medical, Inc. is a specialty pharmaceutical company. The Company specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The Company focuses on central nervous systems (CNS) diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease (AD), dementia symptoms and neuromuscular diseases. The Company has exclusive worldwide rights to develop and commercialize product platforms based on its proprietary isoform transcribed from the human Klotho gene referred to as secreted Klotho or s-KL. This s-KL protein or gene therapy has been recognized for its potential to mitigate age-related pathologies such as ALS, Alzheimer's and Parkinson's Disease. Its lead gene therapy product candidates are AMI-101 (AAV9-CMV-sKL) for the treatment or prevention of Alzheimer’s disease, and AMI-202 (AAVmyo-Des-sKL) gene therapy product for treatment and prevention of Lou Gehrig’s disease.